Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Next Generation Antibody Therapeutics Market 2025 by Company, Regions, Type and Application, Forecast to 2031

date 02 Jan 2025

date Medical Care

new_biaoQian Next Generation Antibody Therapeutics

According to our (Global Info Research) latest study, the global Next Generation Antibody Therapeutics market size was valued at US$ 12610 million in 2024 and is forecast to a readjusted size of USD 43900 million by 2031 with a CAGR of 19.5% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Next Generation Antibody Therapeutics Supply, Demand and Key Producers, 2024-2030

date 09 Sep 2024

date Medical Care

new_biaoQian Next Generation Antibody Therapeutics

Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.

USD4480.00

Add To Cart

Add To Cart

Global Next Generation Antibody Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 09 Sep 2024

date Medical Care

new_biaoQian Next Generation Antibody Therapeutics

Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.

USD3480.00

Add To Cart

Add To Cart

Global Next Generation Antibody Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Care

new_biaoQian Next Generation Antibody Therapeutics

Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.

USD3480.00

Add To Cart

Add To Cart

According to our (Global Info Research) latest study, the global Next Generation Antibody Therapeutics market size was valued at US$ 12610 million in 2024 and is forecast to a readjusted size of USD 43900 million by 2031 with a CAGR of 19.5% during review period.

USD3480.00

addToCart

Add To Cart

Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.

USD4480.00

addToCart

Add To Cart

Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.

USD3480.00

addToCart

Add To Cart

Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.

USD3480.00

addToCart

Add To Cart